Dong-A ST Co., Ltd. (170900.KS)
KRW 47300.0
(-1.77%)
KRW 47300.0
(-1.77%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1315.21 Billion KRW | 13.6% |
| 2022 | 1157.72 Billion KRW | 3.74% |
| 2021 | 1115.98 Billion KRW | 13.8% |
| 2020 | 980.66 Billion KRW | -2.79% |
| 2019 | 1008.77 Billion KRW | 6.34% |
| 2018 | 948.67 Billion KRW | 5.44% |
| 2017 | 899.71 Billion KRW | -15.65% |
| 2016 | 1066.61 Billion KRW | 0.29% |
| 2015 | 1063.53 Billion KRW | -1.69% |
| 2014 | 1081.85 Billion KRW | 16.11% |
| 2013 | 931.71 Billion KRW | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 1429.75 Billion KRW | 9.06% |
| 2024 Q1 | 1310.98 Billion KRW | -0.32% |
| 2023 Q4 | 1315.21 Billion KRW | 3.67% |
| 2023 Q1 | 1174.63 Billion KRW | 1.46% |
| 2023 FY | 1315.21 Billion KRW | 13.6% |
| 2023 Q3 | 1268.61 Billion KRW | 1.15% |
| 2023 Q2 | 1254.24 Billion KRW | 6.78% |
| 2022 FY | 1157.72 Billion KRW | 3.74% |
| 2022 Q1 | 1177.04 Billion KRW | 5.47% |
| 2022 Q2 | 1173.49 Billion KRW | -0.3% |
| 2022 Q4 | 1157.72 Billion KRW | -3.64% |
| 2022 Q3 | 1201.5 Billion KRW | 2.39% |
| 2021 Q4 | 1115.98 Billion KRW | -1.77% |
| 2021 Q2 | 991.41 Billion KRW | 0.31% |
| 2021 FY | 1115.98 Billion KRW | 13.8% |
| 2021 Q1 | 988.31 Billion KRW | 0.78% |
| 2021 Q3 | 1136.12 Billion KRW | 14.6% |
| 2020 Q1 | 1071.96 Billion KRW | 6.26% |
| 2020 FY | 980.66 Billion KRW | -2.79% |
| 2020 Q4 | 980.66 Billion KRW | -3.28% |
| 2020 Q3 | 1013.87 Billion KRW | -0.35% |
| 2020 Q2 | 1017.44 Billion KRW | -5.09% |
| 2019 Q3 | 1034.84 Billion KRW | 2.34% |
| 2019 Q4 | 1008.77 Billion KRW | -2.52% |
| 2019 Q1 | 975.6 Billion KRW | 2.84% |
| 2019 FY | 1008.77 Billion KRW | 6.34% |
| 2019 Q2 | 1011.21 Billion KRW | 3.65% |
| 2018 FY | 948.67 Billion KRW | 5.44% |
| 2018 Q4 | 948.67 Billion KRW | -1.11% |
| 2018 Q3 | 959.35 Billion KRW | -0.19% |
| 2018 Q2 | 961.15 Billion KRW | 0.45% |
| 2018 Q1 | 956.88 Billion KRW | 6.35% |
| 2017 Q1 | 1015 Billion KRW | -4.84% |
| 2017 Q2 | 995.18 Billion KRW | -1.95% |
| 2017 Q3 | 921.26 Billion KRW | -7.43% |
| 2017 Q4 | 899.71 Billion KRW | -2.34% |
| 2017 FY | 899.71 Billion KRW | -15.65% |
| 2016 Q2 | 1043.34 Billion KRW | -1.57% |
| 2016 FY | 1066.61 Billion KRW | 0.29% |
| 2016 Q4 | 1066.61 Billion KRW | 4.94% |
| 2016 Q3 | 1016.44 Billion KRW | -2.58% |
| 2016 Q1 | 1059.93 Billion KRW | -0.34% |
| 2015 Q4 | 1063.53 Billion KRW | 1.42% |
| 2015 FY | 1063.53 Billion KRW | -1.69% |
| 2015 Q3 | 1048.65 Billion KRW | -4.91% |
| 2015 Q2 | 1102.79 Billion KRW | 1.91% |
| 2015 Q1 | 1082.15 Billion KRW | 0.03% |
| 2014 FY | 1081.85 Billion KRW | 16.11% |
| 2014 Q1 | 947.06 Billion KRW | 1.65% |
| 2014 Q2 | 1001.18 Billion KRW | 5.71% |
| 2014 Q3 | 1009.78 Billion KRW | 0.86% |
| 2014 Q4 | 1081.85 Billion KRW | 7.14% |
| 2013 Q2 | 940.88 Billion KRW | 0.0% |
| 2013 Q3 | 944 Billion KRW | 0.33% |
| 2013 Q4 | 931.71 Billion KRW | -1.3% |
| 2013 FY | 931.71 Billion KRW | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Yuyu Pharma, Inc. | 198.21 Billion KRW | -563.537% |
| Dong-A Socio Holdings Co., Ltd. | 1957.1 Billion KRW | 32.798% |
| Ilyang Pharmaceutical Co.,Ltd | 468.9 Billion KRW | -180.489% |
| Ildong Pharmaceutical Co., Ltd. | 611.26 Billion KRW | -115.165% |
| Ildong Holdings Co., Ltd. | 876.99 Billion KRW | -49.968% |
| Hana Pharm Co., Ltd. | 348.38 Billion KRW | -277.518% |
| Kukje Pharma Co., Ltd. | 170.61 Billion KRW | -670.848% |
| Yuhan Corporation | 2814.07 Billion KRW | 53.263% |
| SAMSUNG PHARM. Co., LTD. | 93.47 Billion KRW | -1306.968% |
| Hanall Biopharma Co.,Ltd | 239.74 Billion KRW | -448.587% |
| Dong Sung Bio Pharm.Co.,Ltd. | 114.97 Billion KRW | -1043.935% |
| MYUNGMOON Pharm co.,Ltd | 236.54 Billion KRW | -456.004% |
| Samjin Pharmaceuticals Co., Ltd. | 419.9 Billion KRW | -213.221% |
| CKD Bio Corp. | 293.78 Billion KRW | -347.681% |
| Yuyu Pharma, Inc. | 198.21 Billion KRW | -563.537% |
| REYON Pharmaceutical Co., Ltd. | 499.77 Billion KRW | -163.162% |
| Aprogen pharmaceuticals,Inc. | 589.39 Billion KRW | -123.147% |
| JW Pharmaceutical Corporation | 645.03 Billion KRW | -103.898% |
| Shin Poong Pharm.Co.,Ltd. | 350.08 Billion KRW | -275.687% |
| Hyundai Pharmaceutical Co., Ltd. | 154.04 Billion KRW | -753.811% |
| Yungjin Pharm. Co., Ltd. | 226.6 Billion KRW | -480.413% |
| HANDOK Inc. | 790.33 Billion KRW | -66.412% |
| Yuyu Pharma, Inc. | 198.21 Billion KRW | -563.537% |
| Kwang Dong Pharmaceutical Co., Ltd. | 1078.06 Billion KRW | -21.998% |
| Daewoong pharmaceutical Co.,Ltd | 1770.31 Billion KRW | 25.707% |
| JW Pharmaceutical Corporation | 645.03 Billion KRW | -103.898% |
| Yuhan Corporation | 2814.07 Billion KRW | 53.263% |
| Jeil Pharma Holdings Inc | 879.99 Billion KRW | -49.457% |
| Hanmi Pharm. Co., Ltd. | 1952.03 Billion KRW | 32.623% |
| Chong Kun Dang Pharmaceutical Corp. | 1402.42 Billion KRW | 6.218% |
| Suheung Co., Ltd. | 993.73 Billion KRW | -32.351% |
| JW Pharmaceutical Corporation | 645.03 Billion KRW | -103.898% |
| Chong Kun Dang Holdings Corp. | 1456 Billion KRW | 9.669% |
| Ilsung Pharmaceuticals Co., Ltd. | 419.18 Billion KRW | -213.753% |
| JW Holdings Corporation | 1176.26 Billion KRW | -11.813% |
| Samil Pharmaceutical Co.,Ltd | 370.68 Billion KRW | -254.813% |
| Jeil Pharmaceutical Co.,Ltd | 487.32 Billion KRW | -169.885% |
| Shin Poong Pharm.Co.,Ltd. | 350.08 Billion KRW | -275.687% |
| Daewon Pharmaceutical Co., Ltd. | 507.99 Billion KRW | -158.902% |
| Korea United Pharm Inc. | 468.86 Billion KRW | -180.514% |
| Whan In Pharm Co.,Ltd. | 401.22 Billion KRW | -227.8% |
| Dongwha Pharm.Co.,Ltd | 564.97 Billion KRW | -132.794% |
| Boryung Corporation | 922.36 Billion KRW | -42.593% |
| Bukwang Pharmaceutical Co., Ltd. | 442.46 Billion KRW | -197.25% |
| Ilyang Pharmaceutical Co.,Ltd | 468.9 Billion KRW | -180.489% |
| JW Lifescience Corporation | 255.83 Billion KRW | -414.086% |